Application Note: Extending the Lifetime of GORE® Protein Capture Devices through Alternative Cycling Parameters
Technical Information, 147.61 KB
This evaluation demonstrates a method to extend the lifetime of a GORE Protein Capture Device from 20 to 50 cycles while maintaining capacity as assessed by Dynamic Binding Capacity (DBC) at 10% breakthrough, yield, and purity.
Traditional affinity chromatography technology has not kept pace with increased titers and other upstream process improvements, leading to bottlenecks and lower productivity in downstream purification. To gain flow and shorten processing times, traditional resin-based Protein A is often over-sized or underutilized – simply to keep up.*
Increase productivity: GORE Protein Capture Devices with Protein A utilize a unique membrane solution that provides a binding capacity advantage at high flow rates and improves the speed of purification versus traditional technologies. Compare our Dynamic Binding Capacity (DBC) to that of agarose bead-based columns:
GORE Protein Capture Devices are approximately 6-10x faster than traditional agarose bead-based technology which operates at typical residence times of 3–5 minutes (180–300 seconds).
Designed for affinity purification in early drug discovery screening, late stage optimization, process development, and clinical applications for
- monoclonal antibodies (mAbs)
- next generation molecules that utilize the FC region for Protein A binding
The columns are compatible with standard chromatography systems.
|PROA101||1.0 mL device||Drug discovery|
|PROA102||3.5 mL device||Drug discovery|
|PROA103||9.0 mL device||Drug discovery, late stage optimization, process development, early GMP applications|
|PROA201||58 mL device||Process development, clinical (GMP) applications|
|PROA202||116 mL device||Clinical (GMP) applications|
|PROA203||232 mL device||Clinical (GMP) applications|
GORE Protein Capture Devices with immobilized Protein A* can improve throughput and yields in downstream purification by reducing overall process time. These pre-packed columns use a unique ePTFE membrane that offers high dynamic binding capacity at short residence time. The 58 mL - 232 mL accommodate rapid cycle capability at low pressure drop, along with demonstrated ability to withstand multiple cleaning cycles. This increased productivity offers researchers the potential for a faster path to clinical trials.
PROA102 (3.5 mL)
PROA201 (58 mL)
PROA202 (116 mL)
|Dynamic binding capacity||≥ 30 mg/mL||≥ 40 mg/mL|
|Residence time||20 seconds||30 seconds|
|Number of cleaning cycles||0.2 N NaOH for 3 minutes up to 50 cycles||0.2 N NaOH for 3 minutes up to 100 cycles|
*recombinant Protein A
The GORE Protein Capture Device scales across sizes without compromising binding capacity or speed to quickly and effectively capture antibodies as shown in this overlay of a 1mL, 9mL and 58mL bind-elute curve.
For complete technical and product performance information, including detailed test parameters, additional yield data, purity profiles, operating conditions and more, download our data sheet.
The GORE Protein Capture Device can streamline antibody purification processes because it incorporates a proprietary ePTFE membrane composite.
Unlike traditional support matrices, the composite membrane bed maintains a linear relationship between pressure drop and a wide range of flow rates. Because this unique structure remains stable, the membrane bed is not vulnerable to collapse, channeling or alteration of the bed.
Performance under pressure
Pressure Drop for 58mL Device (PROA201)
Materials of construction
|Components||GORE PART NUMBER|
|PROA101 / PROA102||PROA103||PROA201||PROA202
|Device housing components||Polypropylene||Polypropylene and Polyether ether ketone (PEEK) primarily*|
|Frit material(s)||Polypropylene||Polyether ether ketone (PEEK) Polyvinylidene fluoride (PVDF)|
|Membrane support matrix||Proprietary ePTFE composite|
|Ligand||Recombinant Protein A|
|Connectors||10/32” threaded fittings||10-32 coned thread port||5/16-24 Flat-bottom fittings||3/4" Tri clamp (0.984" (OD))|
* See datasheet or contact Gore for validation guide with additional details
GORE Protein Capture Devices are compatible with standard pre-packed column chromatography systems, and are available in 1.0 ml, 3.5mL, 9.0mL, 58mL, 116 mL and 232 mL sizes. Contact Gore for pricing and availability. Not available in all regions.
Part Number/Ordering Information
|PROA101||1.0 mL Device|
|PROA102||3.5 mL Device|
|PROA103||9.0 mL Device|
|PROA201||58 mL Device|
|PROA202||116 mL Device|
|PROA203||232 mL Device|
See Validation Guides for performance specifications and evaluations.
Regulatory Compliance and Quality
GORE Protein Capture Devices are manufactured following the applicable material quality and regulatory requirements, including relevant Good Manufacturing Processes as defined in the Gore PharmBIO quality system which is certified to ISO 13485 and ISO 15378. Contact Gore for current applicable compliance statements and quality control information.
Application Note: Cleaning Protocols to Reduce Effects of Pressure Rise Over the Lifetime of a GORE® Protein Capture Devices
Technical Information, 471.19 KB
Data Sheets, 242.9 KB
Gore PharmBIO Introduces 116mL and 232mL Protein Capture Devices with Protein A to Increase Productivity and Throughput for Antibody Purification
Posted April 5, 2022
W.L. Gore & Associates, Inc. continues to build on its growing portfolio of protein capture devices with the introduction of its new 116mL and 232mL GORE® Protein Capture Devices with Protein A. The offerings strengthen Gore’s chromatography device portfolio and follow the commercial availability of its 58mL Protein Capture Device in Q4 of 2021.
March 29, 2022 - April 1, 2022
Visit GORE in-person or virtually at this year’s World ADC Europe. Gore is participating as an exhibition partner to showcase expertise in providing leading pharmaceutical companies with an innovative, Protein A membrane chromatography device to improve productivity in affinity purification of monoclonal antibodies. Discuss how a membrane column could be the missing single use purification link.
March 22, 2022 - March 24, 2022
Visit GORE at Bioprocessing Summit Europe 2022 March 22, 2022 - March 24, 2022 Barcelona, Spain
Posted March 20, 2020
Gore is adding to it's range of affinity chromatography devices with the larger 9.0 mL size device for applications in process development, pre-clinical and early clinical drug development. This launch is significant because it demonstrates that this innovative membrane technology can be scaled to larger sizes without losing performance benefits.